Brighter sells its holdings in Blodtrycksdoktorn AB for SEK 5 million
Brighter AB (Publ) today announced it has entered into an agreement with one of the shareholders of Blodtrycksdoktorn AB (formerly known as Accumbo AB) to sell its entire holdings in Blodtrycksdoktorn AB for SEK 5 million.
Brighter agreed to sell its entire holdings in Blodtrycksdoktorn AB for SEK 5 million, and payment in cash will be made on the closing date, currently estimated to be 21 December 2021.
During the fall of 2021, the board and management made a strategic evaluation of the Company and decided to streamline its operations to fully focus on its core business of digital solutions for connected and data-driven diabetes care. The sale of the investment in Blodtrycksdoktorn was part of the decisions made to further support the strategic development.
“I am very pleased that we have now taken another step on the journey towards streamlining our core business. We have succeeded to sell our subsidiary Camanio and now our holdings in Blodtrycksdoktorn. In addition, we continue with our ongoing discussions with stakeholders to sell some or all of our interest in our subsidiary Nectarine Health,” said Brighter’s chairman of the board Christer Trägårdh.
For more information, please contact:
Investor Relations
ir@brighter.se
Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB, +46 [0)8 - 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. https://brighter.se/
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:50 CET on 16 December 2021.